Ed Arcee
Analyst, HC Wainwright
Replay available
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q4 2024 earnings conference call, held 2025-02-28. Replay captured from the company's public earnings webcast.

Analyst, HC Wainwright
Analyst, Jefferies
Analyst, TD Cowan
Head of Corporate Communication and Investor Relations
Analyst, Cantor Fitzgerald
Chief Medical Officer
Chief Financial Officer
President and Chief Executive Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Aurinia Pharmaceuticals Inc.
WEBVTT 00:00:00.031 -- 00:00:04.796 Greetings and welcome to the Arinia Pharmaceuticals fourth quarter and full year 2024 00:00:04.796 -- 00:00:09.822 earnings call. At this time, all participants are in a listen-only mode. 00:00:09.822 -- 00:00:13.246 A question and answer session will follow the formal presentation. 00:00:13.246 -- 00:00:16.730 If anyone should require operator assistance during the conference, please press star 00:00:16.730 -- 00:00:21.776 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:21.776 -- 00:00:26.922 I would now like to turn the conference over to your host, Andrea Christopher, Head of 00:00:26.922 -- 00:00:30.153 Corporate Communication and Investor Relations for Arinia. 00:00:30.153 -- 00:00:33.254 Thank you. You may begin. 00:00:33.256 -- 00:00:37.900 Thank you, Operator, and thank you to everyone for joining today's call and webcast. 00:00:37.900 -- 00:00:41.383 Joining me on the call this morning are Peter Greenleaf, Arania's President and Chief 00:00:41.383 -- 00:00:45.867 Executive Officer, Joe Miller, Arania's Chief Financial Officer, and Dr. 00:00:45.867 -- 00:00:48.790 Greg Keenan, Arania's Chief Medical Officer. 00:00:48.790 -- 00:00:53.294 Today, we will review and discuss Arania's fourth quarter and full year 2024 financial 00:00:53.294 -- 00:00:58.358 results and provide an update on recent corporate progress, as communicated in the company's 00:00:58.358 -- 00:01:03.077 press release and annual report, on Form 10K issued this morning. 00:01:03.077 -- 00:01:06.602 For more information, please refer to ARINIA's filings with the U.S. 00:01:06.602 -- 00:01:11.088 Securities and Exchange Commission and Canadian Securities Authorities, which are also 00:01:11.088 -- 00:01:15.114 available on...